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NASA, Moffett Field, Cal i fornia  94035 
The common associat ion of sympathoadrenal and p i t u i t a r y  adre- 
nocort ical  a c t i v i t y  i n  stress has suggested that catecholamines 
play a spec ia l  r o l e  i n  regulating ACTH secretion. 
have been proposed through t h e  years t o  explain t h i s  relationship.  
These included (a) Long's concept (1952) t h a t  emotional s t i m u l i  
a c t iva t e  t h e  hypothalamus which i n  t u r n  stimulates t h e  adrenal 
medulla v i a  t h e  sp ina l  cord and splanchnic nerves, and t h e  subse- 
quently released epinephrine stimulates t h e  release of ACTH; 
( b )  For t ie r  e t  al .  s (1957) c l a s s i f i ca t ion  of emotional (epineph- 
r i n e  mediated) versus systemic stresses; (c )  Smelik' s (1959) svg- 
ges t ion  that "neurotropic" stresses result i n  t h e  release of 
epinephrine f r o m t h e  adrenal medulla which would i n  tu rn  ac t iva t e  
"hypothalamic nervous pathways leading t o  t h e  neurohy-pophysis; and 
(d)  involvement of hypothalamic norepinephrine i n  t h e  regulation 
of p i t u i t a r y  function (Vogt, 1954; Carlsson et  al.,  1962; Vernikos- 
Danellis, 1965). 
any one of these theor ies  and t h e  vas t  number of reports  i n  the  
l i terature using indiscriminately various psychodepressants and 
psychic energizers t o  "elucida,te" t h e  involvement of catecholamines 
i n  p i t u i t a r y  ACTH secret ion have merely added t o  t h e  confusion. 
T h i s  is  brought out nicely i n  the  review by De Wied (1967) on t h e  
effects  of chlorpromazine on endocrine function. 
Several  theories  
There i s  almost as much evidence fo r ,  as against  
I n  a recent series of experiments (Vernikos-Danellis, 1966) it 
w a s  observed tha t  pretreatment of rats with one of t h e  m e t h y l  
xanthines, caffeine or theophylline, enhanced t h e  stress-induced 
secret ion of ACTH and antagonized the  a b i l i t y  of s te ro ids  t o  
inh ib i t  hypothalamic -p i tu i ta ry  ACTH secretion. 
xanthines have been shown i n  a var ie ty  of t i s s u e s  t o  inh ib i t  - i nSince these  m e t h y l  
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v i t r o  the  3' 5' nucleotide phosphodiesterase t h a t  breaks down cycl ic  
3 '5 '  adenosine monophosphate (AMP) and t o  poten t ia te  t h e  cyclic 
AMP-mediated e f fec ts  of various hormones both i n  v i t r o  and _.- i n  vivo 
(Sutherland and R a l l ,  1958; Butcher and Sutherland, 1962; Wnie 
e t  a l . ,  1966; Hess e t  a l . ,  1963), t he  poss ib i l i t y  existed t h a t  
these drugs exerted t h e i r  e f fec ts  on t h e  hypothalamic-pituitary 
unit  by a similar mechanism. 
phosphodiesterase i n  various t i s sues  of t h e  rat (Vernikos -Danellis 
and Harris, 1966, unpublished) indicated high a c t i v i t y  i n  both the  
median eminence and the  anter ior  p i tu i t a ry  gland as  compared t o  
other organs. Furthermore, t h i s  enzyme was markedly depressed f o l -  
lowing incubation with one of the  methyl xanthines i n  r e l a t ive ly  
large concentrations but a l so  showed a 3O$ decrease i n  a c t i v i t y  i n  
the  p i tu i t a ry  i n  -- i n  vivo experiments under t h e  condit%ons tha t  
showed enhancement of t he  p i tu i t a ry  ACTH stress response. 
P-adrenergic blocking d r ~ s  a r e  generally believed t o  exert  t h e i r  
e f fec ts  by inhibi t ing the  ac t iva t ion  of adenyl cyclase (Murad e t  
a l . ,  1962; Robison e t  a l . ,  1967). O f  these MJ-1999 
[ (2-Isopropylamino, 1-Hydroxyethyl) methanesulfonanilide) 1 offers  
advantages by being devoid of i n t r i n s i c  adrenergic ac t iv i ty .  Fig- 
ure 1 shows the  r e s u l t s  of a n  experiment designed t o  determine 
whether MJ-1999 could prevent the  increase i n  ACTH secretion f o l -  
lowing ether s t r e s s  and the  potent ia t ion of t h i s  response by 
caffeine.  
-- 
Studies on t h e  d is t r ibu t ion  of the  
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Figure 1. Changes i n  the  concentration of corticotropin releasing 
ac t iv i ty ,  p i tu i t a ry  and plasma ACTH before and 2.5 minutes a f t e r  
s t r e s s  (e ther  1 min.) i n  rats pretreated with sal ine,  caffeine, or 
MJ-1999 30 minutes previously. CRF content i s  expressed as IJ.Q 
corticosterone per 100 mg adrenal t i s s u e  i n  rats given a subcuta- 
neous in jec t ion  of 2.5 mg prednisolone 4 hours ea r l i e r ,  resu l t ing  
from t h e  intravenous in jec t ion  of a crude ac id  extract  of 1 r a t  
median eminence. 
t i s s u e  or mu/lOO m~.. plasma. 
P i tu i t a ry  and plasma ACTH w a s  expressed as mu/mg 
Throughout t h i s  work female Sprague-Dawley rats weighing 100 
t o  120 g. were used as t h e  donors. Plasma and p i t u i t a r y  ACTH con-' 
centrat ions were determined i n  male rats af t h e  same weight and 
s t r a i n  4 hours after hypophysectomy or 4 hours after a subcutaneous 
in jec t ion  of 2.5 mg prednisolone per 100 g .  body weight for  CRF 
determinations. I n  these methods t h e  increasy i n  adrenal c o r t i -  
costerone concentration produced by one or more d i lu t ions  of t h e  
sample i s  compared t o  two doses of standard ACTH. 
Danellis e t  a l . ,  1966) . 
(Vernikos- 
A dose of 4 m g / l O O  g .  body weight of MJ-1999 w a s  given sub- 
cutaneously 30 minutes p r io r  t o  caffeine ( 2  m g / l O O  g .  s . ~ . )  or  
sa l ine  administration. Thir ty  minutes later half  t h e  animals i n  
each group were stressed with ether (one minute) and decapitated 
2.5 minutes after the  beginning of t he  e ther ;  The remaining an i -  
mals served as unstressed%ontrols .  
times as grea t  as t h a t  which i s  reported t o  prevent t h e  r i se  i n  t h e  
i s  opr o t  er e no1 -induced a c t  iva t  ion of myoc ar d i  a1 phosphorylas e i n  
t h e  rat (Kvam e t  a l . ,  1965). The r e s u l t s  show t h a t  it a l s o  pre- 
vented t h e  stress-induced secret ion of ACTH, and markedly depressed 
t h e  increase i n  p i t u i t a r y  ACTH and t h e  enhancement of t h e  ether 
stress usually seen after caffeine.  
This dose of MJ-1999 i s  4 
Since catecholamines, vasopressin, and histamine share the  
property of act ivat ing adenyl cyclase i n  d i f fe ren t  t i s sues  or 
exerting t h e i r  e f f ec t s  through the  mediation of cycl ic  AMP 
(Robison et a l . ,  1967) and have a l s o  been implicated at one t i m e  
or another i n  t h e  mechanism regulating ACTH secretion, it became 
of i n t e re s t  t o  determine whether these substances could a l s o  poten- 
t i a t e  t h e  secret ion of ACTH i n  response t o  a subsequent stress and 
whether a straightforward pharmacological study using a- and 
P-adrenergic blocking agents would y i e ld  any informat ion about the 
mechanism of act ion of these substances, i n  t h e  endocrine response 
t o  s t r e s s .  
Female rats kept under control led environmental conditions 
were given a s ingle  in t raper i tonea l  in jec t ion  of saline solutions 
of isoproterenol (80 pg) , epinephrine (80 or 160 pg) , norepineph- 
r i n e  (80 or 160 pg) , dopamine (1 mg) , vasopressin (500 m u ) ,  h i s t a -  
mine (300 pg) , or 0.9$ normal sa l ine  (0.2 m l )  . 
paper a l l  doses are expressed as weight un i t s  of free base. Ten 
minutes after t h e  in jec t ion  they w e r e  decapitated and t h e  plasma 
separated from t h e  pooled heparinized blood, was frozen and s tored 
a t  -12' C u n t i l  assayed for  i t s  ACTH content. 
i n  Table  1, indicate  that norepinephrine i s  more potent than epi-  
nephrine which i s  i n  t u r n  more potent than isoproterenol i n  stimu- 
l a t i n g  ACTH secretion, and t h a t  dopamine, histamine, and 
vasopressin i n  larger  amounts have a similar effect. Since t h e  
potency of t h e  catecholamines i n  t h i s  respect appeared t o  be 
Throughout t h i s  
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re la ted  t o  t h e i r  pressor ac t iv i ty ,  a similar se r i e s  of experiments 
was performed i n  rats given i . p .  30 minutes e a r l i e r  1 mg of the  
a-adrenergic blocking agent phentolamine. 
agreement with previous observations (Tepperman and Bogardus, 1948; 
Guillemin, 1955; George and Way, 1957; Van Peenen and Way, 1957) 
t h a t  a-adrenergic blocking agents do not i nh ib i t  the  response t o  
stresses other t h a n  epinephrine and extend t h i s  observation t o  
include norepinephrine and dopamine. The increase i n  c i rculat ing 
ACTH Concentration caused by histamine or vasopressin administra- 
t i o n  or exposure t o  ether was not affected by pretreatment with 
phentolamine. I n  contrast ,  previous experiments (Figure 1) had 
shown t h a t  pretreatment of animals with the  P-adrenergic blocking 
agent MJ-1999 ef fec t ive ly  inhibi ted t h e  stress-induced ACTH secre- 
t i o n  following ether .  
drug might inh ib i t  other types of s t resses  and thus suggest a r o l e  
for catecholamines common t o  a l l  types of s t r e s s  i n  the  mechanism 
regulating ACTH secretion. The r e su l t s  i n  Table 1 show tha t  
j.3 -adrenergic blocker injected subcutaneously 30 minutes ea r l i e r  i n  
a dose of 4 mg/lOO g-body weight, markedly inh ib i t s  t h e  acute p i tu -  
i t a r y  response t o  epinephrine and ether and surprisingly reduces 
tha t  t o  vasopressin. 
The results are i n  
It therefore appeared possible that t h i s  
Since those substances w i t h  greatest  P-adrenergic a c t i v i t y  
were l e a s t  effect ive i n  stimulating ACTH secret ion and since the  
P-adrenergic blocker was previously shown t o  inh ib i t  t he  a b i l i t y  of 
caffeine t o  enhance ether s t r e s s ,  experiments were designed t o  com- 
pare the a b i l i t y  of the  substances studied t o  enhance a second 
s t r e s s  and t o  determine whether a- or P-adrenergic blockade 
affected t h i s  property. Thirty minutes before exposure t o  one min- 
ute  of ether s t r e s s  r a t s  were given t h e  following substances: 
sa l ine  (0.2 m l )  , isoproterenol (80 pg),  epinephrine (80 pg) , 
norepinephrine (80 pg) , dopamine (1 mg) , vasopressin (250 or 500 
m u ) ,  histamine (300 pg) . 
a f t e r  the  beginning of t h e  ether and t h e i r  plasma ACTH content 
determined. Where a-blockade was required phentolamine w a s  admin- 
i s t e r ed  30 minutes before the in jec t ion  of t h e  neurohumor or one 
hour before the  ether s t r e s s .  The time sequence w a s  therefore:  
phentolamine followed 30 minutes l a t e r  by t h e  neurohumor, followed 
30 minutes l a t e r  by one minute ether and decapitation a t  2.5 min- 
utes a f t e r  the  beginning of t he  ether s t r e s s .  Since MJ-1999 inhib- 
i t e d  the  ether s t r e s s  per se, the  timing was selected i n  such a way 
as t o  allow t h e  response t o  ether t o  r e tu rn  yet maintain adequate 
0-adrenergic blockade at  the  time of t h e  inject ion.  It is  of i n t e r -  
es t  here t o  note tha t  t he  inhibi t ion of the ether s t r e s s  was very 
t rans ien t  as compared t o  the  e f fec t  of the  blocker on t h e  enhance- 
ment of a second stress by e-pinephrine which l a s t ed  at  least 4 
hours, (unpublished observations). The t i m e  sequence i n  t h i s  se r ies  
of experiments w a s  therefore; MJ-1999 followed 2.5 hours l a t e r  by 
the  in jec t ion  of t h e  neurohumor, followed 30 minutes l a t e r  by one 
All animals were decapitated 2.5 minutes 
minute ether  and decapi ta t ion at 2.5 minutes a f t e r  t h e  beginning of 
t he  ether  s t r e s s .  Table 2 shows t h a t  epinephrine, isoproterenol,  
and vasopressin were a l l  e f fec t ive  i n  enhancing t h e  ACTH secre t ion  
i n  response t o  ether s t r e s s .  
norepinephrine were without e f fec t ;  sect ion C of Table 2 shows how- 
ever, that increasing t h e  dose of norepinephrine t o  160 pg and t h e  
in t ens i ty  of t he  s t r e s s  t o  ether followed by laparotom;y resu l ted  
i n  a s ign i f icant  enhancement of ACTH secret ion.  Section B of 
Table 2 shows that i f  histamine stress i s  subs t i tu ted  fo r  t h e  
ether,  epinephrine pretreatment s t i l l  enhanced t h i s  stress response 
while vasopressin d id  not .  
a c t i v i t y  of t h e  catecholamines the  order t o  potency of these sub- 
stances i n  enhancing a second s t r e s s  was: i sop ro te reno l>  e.pineph- 
r i n e  > norepinephrine. Pretreatment with phentolamine d id  not 
alter t h e  potent ia t ing a b i l i t y  of these substances and i n  f ac t  
increased t h a t  of ,e@nephrine. Pretreatment with t h e  p-blocker, 
W-1999, abolished t h e  enhancing propert ies  of a l l  t he  substances 
t e s t e d  including vasopressin. 
Histamine, dopamine, and 80 pg of 
I n  contrast  t o  t h e  ACTH stimulating 
I n  order t o  determine the  s i t e  of ac t ion  of these two d i f f e r -  
ing e f f ec t s  of per ipheral ly  administered catecholamines, the  c o r t i -  
cotropin releasing a c t i v i t y  (as measured by t h e  increase i n  adrenal 
corticosterone) of a crude ac id  extract  of rat median eminence 
(MEE) w a s  compared i n  rats i n  which t h e  endogenous secret ion of 
CRF was e f f ec t ive ly  inh ib i ted  by a s ingle  subcutaneous in jec t ion  
of prednisolone (2.5 mg/lOO g- 4 hours e a r l i e r )  with animals given 
phentolamine only, s t e ro id  plus phentolamine, or normal sa l ine  
only ( see  Table 3 ) .  Phentolamine in jec ted  3-1/2 hours a f t e r  t h e  
s t e ro id  and 30 minutes before use of the  animals was without e f f ec t  
i n  preventing t h e  stress of ether and intravenous sa l ine  and t h e  
response of t h e  p i t u i t a r y  t o  MEE, nor did it a f f e c t  the  s e n s i t i v i t y  
of t h e  adrenal cortex t o  injected ACTH. 
Table 4 shows a similar se r i e s  of experiments using MJ-1999 
Once more t h e  blocker w a s  administered instead of phentolamine. 
30 minutes before use of t he  animals. 
not only t h e  increase i n  adrenal corticosterone resu l t ing  from the  
s t r e s s  of e ther  and intravenous sa l ine  but a l s o  that r e f l ec t ing  t h e  
cort icotropin releasing a c t i v i t y  of t h e  median eminence extract  
both i n  t h e  presence and i n  t h e  absence of t he  s te ro id .  
t o  eliminate t h e  poss ib i l i t y  that t h i s  inh ib i t ion  w a s  exerted at  
t h e  adrenal level ,  t h e  increase i n  adrenal cor t icosterone i n  
response t o  two doses of standard ACTH was compared i n  s t e ro id  
blocked rats with and without MJ-1999. The adrenergic blocker had 
no d i r ec t  e f f ec t  on t h e  responsiveness of t h e  adrenal cortex t o  
ACTH indicating t h a t  i t s  s i te  of ac t ion  i n  depressing t h e  c o r t i -  
cotropin releasing a c t i v i t y  of MEE w a s  exerted primarily at the  
p i tu i t a ry .  
MJ-1999 markedly depressed 
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These findings suggested t h e  hypothesis t h a t  catecholamines 
secreted per ipheral ly  during exposure t o  various stress s i tua t ions  
a f f ec t  t he  hypothalamic p i t u i t a r y  uni t  by at  least two d i s t i n c t  
mechanisms: d i r ec t  st imulation of ACTH secret ion related t o  t h e i r  
a-adrenergic hypertensive properties,  mediated by t h e  hypothalamus 
and possibly r e f l ex ly  by higher centers i n  t h e  cen t r a l  nervous 
system, and a p-adrenergic-receptor-mediated property of enhancing 
the  ACTH secre t ion  t o  a subsequent stress by an ac t ion  primarily on 
t h e  adenohypophysis. 
appears t o  be shared by vasopressin; whether t h i s  i s  an i n t r i n s i c  
e f fec t  of t h i s  peptide or one mediated i n  some way by catechol- 
amines remains t o  be determined. On t h e  other hand t h e  mechanism 
by which histamine stimulates p i t u i t a r y  ACTH secret ion does not 
f a l l  within e i the r  of these  categories .  It i s  of i n t e re s t  t o  point 
out i n  t h i s  respect t h e  recent observation of Dallman (1967) t h a t  
pr ior  exposure t o  t h e  stress of scalding enhances t h e  increase i n  
c i rcu la t ing  corticosterone i n  response t o  histamine whereas pr ior  
administration of histamine has no e f f ec t  on t h e  response t o  
scalding. 
This lat ter property of t h e  catecholamines 
The presence and d i s t r ibu t ion  of catecholamines i n  t h e  cent ra l  
nervous system has been w e l l  documented (Vogt, 1954; Fuxe, 1963; 
Carlsson e t  a l . ,  1962). However, s tudies  with per ipheral ly  admin- 
i s t e r ed  t r i t i a t e d  epinephrine and norepinephrine have shown t h a t  
these substances do not cross the  blood bra in  bar r ie r  although t h e  
anter ior  p i t u i t a r y  takes  up la rge  anflounts of t h e  labe l led  amines; 
t o  a lesser extent so does t h e  median eminence and radioautographic 
s tudies  demonstrate t ha t  they penetrate only a short  distance i n t o  
t h e  hypothalamus (Axelrod et  a l . ,  1959; Weil-Malherbe e t  a l . ,  1961; 
Samorajski and Marks, 1962). 
amines on p i t u i t a r y  ACTH secret ion have proved confusing la rge ly  
because of t h e  lack of spec i f i c i ty  and knowledge of t h e  s i t e  and 
mechanism of ac t ion  of t h e  drugs used t o  deplete or i nh ib i t  synthe- 
sis  of these amines. In t e re s t  i n  a-methyl p-tyrosine (a-MT) stems 
from i t s  a b i l i t y  t o  inh ib i t  tyrosine hydroxylase and thereby t o  
in te r fe re  with the  synthesis of catecholamines (Spector e t  a l .  , 
1965) . This agent depletes norepinephrine s tores  i n  peripheral  
sympathetic nerve endings and reduces t h e  concentrations of norepi- 
nephrine and dopamine i n  t h e  brain.  It is  especial ly  useful  f o r  
studying t h e  r o l e  of bra in  catecholamines s ince (1) it i s  more 
effect ive i n  lowering t h e  concentrations of these amines i n  the 
cen t r a l  nervous system than i n  t h e  periphery (Torchiana e t  a l . ,  
1965)~ (2) it does not influence 5-hydroxytryptamine levels, and 
(3)  unlike a-methyl-m-tyrosine and a-methyldihydroxyphenyl ala- 
n ine ,  it i s  not converted i n t o  "false transmitters" (Spector e t  a l . ,  
1965). It therefore  became of interest t o  use t h i s  drug as a t o o l  
i n  t he  study of t h e  r o l e  of b r a i n  norepinephrine on p i tu i t a ry  ACTH 
secret ion par t icu lar ly  s ince the  long lag  between m a x i m a l  inhibi-  
t i o n  of brain and adrenal medullary amines because of t h e  slower 
catecholamine turnover i n  t h e  adrenal l en t  i t se l f  t o  t h e  
Attempts t o  study t h e  r o l e  of brain 
inves t iga t ion  of t h e  r e l a t i v e  contribution of these two components 
t o  the  funct ional  i n t e g r i t y  of t he  hy-pothalamic -p i tu i ta ry  uni t .  
I n  t h i s  s e r i e s  of experiments t h e  animals were used s i x  hours 
after t h e  in t raper i tonea l  in jec t ion  of a s a l i n e  suspension of a-Mll 
i n  a dose of 200 mg/Kg. body weight, unless otherwise specif ied.  
A similar suspension of 1-tyrosine w a s  in jec ted  i n t o  those animals 
t h a t  served as controls .  A t  t h i s  t i m e  b ra in  amines are markedly 
depressed (Rech e t  a l . ,  1966). 
Figure 2 shows the  plasma corticosterone concentrations 
before and 1.5 minutes following the s t r e s s  of e ther  (one minute) 
i n  rats t h a t  were e i the r  uninjected or had received an in t r ape r i -  
tonea l  i n j ec t ion  of 1-tyrosine or a-MT. The r e s u l t s  show tha t  
t h e  s t r e s s  -induced increase i n  plasma s te ro ids  was reduced i n  t h e  
a-MT t r e a t e d  rats. Figure 3 shows that t h i s  reduced s t e ro id  
response r e f l e c t s  reduced ACTH secret ion i n  response t o  s t r e s s .  
Approximately 50% inh ib i t i on  of t he  ACTH secre t ion  i n  response t o  
the  s t r e s s  of ether and sham adrenalectomy w a s  found and increas- 
ing t h e  dose of a-MT did not i nh ib i t  t h i s  response fur ther .  
Since t h i s  phenomenon could have been due t o  the  a v a i l a b i l i t y  t o  
t h e  median eminence and p i t u i t a r y  of catecholamines or iginat ing 
from t h e  adrenal,  a s i m i l a r  experiment w a s  performed i n  rats 
24 hours a f t e r  adrenalectorqy. 
of t he  adrenal glands female rats show a marked increase i n  t h e  
s e n s i t i v i t y  t o  s t r e s s ,  secret ing greater  amounts of ACTH i n  
response t o  the  r e l a t i v e l y  mild s t r e s s  of one minute ether than do 
in t ac t  animals (Hodges and Vernikos, 1959). 
under these  conditions one-tenth of t h e  dose of a-Mc suf f iced  t o  
cause a 50% inhib i t ion  of t h e  s t r e s s  response and the usual dose of 
A t  t h i s  time period a f t e r  removal 
Figure 4 shows tha t  
0 UNSTRESSED 
a 
_I a
50 
0 
9 
2 4 0  
i 
30 
n 
k 20 
8 
6 10 
0 
CONTROLS I-TYROSINE U-MET TYR 
UNINJECTED 200mg [ Kg zoomg I KQ 
Figure 2. 
utes  following s t r e s s  (e ther  1 min) i n  uninjected rats or animals 
t h a t  had received sfx hours e a r l i e r  a n  in t raper i tonea l  in jec t ion  
of a s a l i n e  suspension of 1-tyrosine or a-methyl tyrosine i n  a dose 
of 200 mg/Kg. 
Plasma corticosterone concentrations before and 15 min- 
Number of animals given i n  parentheses. 
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Figure 3. Plasma ACTH concentrations before and 2.5 minutes after 
s t r e s s  (e ther  1 min. and s h a m  un i l a t e ra l  adrenalectomy) i n  rats 
given s i x  hours earlier an intraperi toneal  in jec t ion  of a sa l ine  
suspension of 200 mg/~g.l-tyrosine or a-methyl tyrosine i n  dose 
of 200 mg or 300 m g / ~ g .  
ETHER ONLY 
ADRENALECTOMIZED 24 hr 
Figure 4. 
stress (ether  1 min. or e ther  1 min. and s h a m  un i l a t e ra l  adrenalec- 
tomy) i n  rats 24 hours after t h e  removal of t h e i r  adrenal glands 
and s i x  hours after an in t raper i tonea l  in jec t ion  of 200 mg/Kg. 
body weight 1-tyrosine or 2, 20, or 200 mg/Kg. of 
tyrosine.  
Plasma ACTH concentrations before and 2.5 minutes after 
a-methyl 
200 mg/Kg. body weight now produced 96$ inhib i t ion  of both ether  
s t r e s s  and t h e  more severe stress of e ther  and s h a m  adrenalectomy. 
Figure 5 i l l u s t r a t e s  t h e  re la t ionship  between percent inh ib i t ion  
of t h e  stress-induced secre t ion  of ACTH and percent inh ib i t ion  of 
whole bra in  norepinephrine i n  intact, sham adrenalectomized and 
24 hour adrenalectomized rats receiving d i f f e ren t  doses of a-MT. 
It would appear that the re  is  a threshold i n  bra in  amine levels 
above which t h e  stress response is  not g rea t ly  a f fec ted  and below 
which small changes i n  amine content markedly a f f ec t  p i t u i t a r y  
ACTH secret ion.  
Experiments i n  progress w i t h  Drs. Levine and Barchas of 
Stanford University studying t h e  e f f ec t s  of t h i s  drug i n  adrenal 
demedullated and chronically adrenalectomized rats, as w e l l  as 
looking i n t o  the  cause of t h e  apparent increased sens i t i v i ty  of 
t h e  adrenalectomized rat t o  inh ib i t ion  of bra in  amines by a-MT 
are t o o  preliminary t o  discuss at t h e  present t i m e .  Nevertheless, 
together with t h i s  ra ther  elementary exercise i n  experimental 
pharmacological design presented here they help t o  point out 
ce r t a in  w e l l  known but neglected f ac t s ,  and suggest new cautions 
i n  t he  in te rpre ta t ion  of results, the building of models and t h e  
art of hypothesizing, with regard t o  t h e  r o l e  of catecholamines i n  
regulating p i t u i t a r y  ACTH secretion. 
The word catecholamines merely denotes s t ruc tu ra l  re la t ionship 
of those biogenic amines, possessing a n  o-dihydroxybenzene r ing.  
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Figure 5. Comparison of t h e  percent inh ib i t ion  of t h e  stress- 
induced secret ion of ACTH and whole brain epinephrine/ 
norepinephrine content i n  in t ac t ,  sham adrenalectomized, and 24 
hour adrenalectomized rats given s ix  hours earlier an in t raper i to-  
neal  in jec t ion  of d i f fe ren t  doses of a-methyl tyrosine.  
It does not denote any kind of uniformity of physiological or 
pharmacological mechanism or s i t e  of action. I n  f ac t  t he  members 
of t h i s  group have l i t t l e  i n  common other than coming through t h e  
same biosynthetic pathway and a r e  characterized by a n  extraordinary 
a b i l i t y  t o  exert similar or d i f fe r ing  e f fec ts  a t  t he  same s i t e ,  
similar e f f ec t s  a t  different  s i t e s ,  or differ ing e f f ec t s  at d i f f e r -  
ent sites. Yet i n  the  study of t h e i r  ro le  on p i tu i t a ry  cort ico-  
t rop ic  secret ion they have been used almost interchangeably and 
of ten t h e i r  ro l e  as  a group emphasized or dismissed on the  r e s u l t s  
of experiments obtained with a s ingle  member. The experiments 
described i n  t h i s  naper perhaps help t o  emphasize t h a t  (a) catechol- 
amines do play a r o l e  i n  regulating ACTH secretion, (b)  t h a t  each 
member of t h e  catecholamine group exerts d i s t i nc t ,  varied and often 
overlapping ef fec ts ,  ( c )  tha t  there  i s  a n  i n t r i c a t e  re la t ionship 
and balance between t h e  ac t  ions of c i rculat ing catecholamines 
exerted a t  p i tu i t a ry  and hypothalamic l eve l  and those exerted by 
central ly  located amines on the various s t ructures  of t he  cent ra l  
nervous system, both stimulant and inhibi tory that appear t o  be 
involved i n  maintaining the  functional s t a t e  of t h e  hypothalamic- 
p i tu i t a ry  ACTH secreting system. 
Final ly  the  physiological significance of the  close associa- 
t i o n  between t h e  glandular t i s sues  of the adrenal cortex and 
medulla has been recent ly  emphasized by the work of Wurtman (1966) 
and of Jos t  and h is  associates (Margolies e t  a l . ,  1966) by the  
demonstration t h a t  the  synthesis of the N-methyl-transferase enzyme, 
which forms epinephrine, i s  under the control of adrenal cortico- 
s te ro id  hormones. Together with the $present findings, it i s  tempt- 
ing t o  suggest i n  addi t ion t o  t h e  w e l l  known negative feedback loop 
between adrenal cortex and cen t r a l  CRF controll ing centers, t he  
existence of a posi t ive feedback loop between adrenal cortex and 
anter ior  p i tu i t a ry  mediated by epinephrine from the  adrenal 
medulla. 
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